Onesource Specialty Pharma LtdPharmaceuticalsINE013P01021Consolidated₹1595.45+16.20 (+1.03%)Jun-26
Valuation
Market Cap₹18.28K Cr
TTM PE-376.16x
Forward PE-231.87x
PEG11.01
Book Value₹508.64
P/B3.14x
TTM EPS₹-4.24
Fwd EPS₹-6.88
TTM Revenue₹1.54K Cr
TTM PAT₹-48.61 Cr
TTM EBITDA₹339.08 Cr
TTM EBIT₹56.03 Cr
Last Qtr PAT₹25.00 Cr
Last Qtr EBITDA₹123.35 Cr
Last Qtr EBIT₹51.60 Cr
Profitability
ROE-0.83%
ROCE2.13%
TTM NPM-3.15%
TTM EBITDA %21.97%
Curr OPM5.52%
Last OPM1.07%
Curr NPM
Last NPM
Curr EPS₹2.18
Last EPS₹0.40
Balance sheet
Equity₹11.46 Cr
Reserve₹5.82K Cr
Total Debt₹1,276.29 Cr
D/E0.22x
Interest %123.24%
Curr Interest₹30.81 Cr
Price / range
Close₹1594.90
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+0.94%
1W+0.19%
1M+3.98%
3M-3.34%
6M+8.42%
1Y-14.38%
2Y
3Y
5Y
Diwali-10.85%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue446.47+39.1%418.96290.22375.19321.011,405.38
Other Income3.792.094.623.045.2615.01
Total Income450.26+38.0%421.06294.84378.22326.271,420.39
Interest30.5222.2537.9933.3127.03120.58
Expenditure-399.03-32.4%-401.25-349.94-341.12-301.45-1,393.76
PBDT000000
EBITDA114.14+42.9%74.7012.84101.5979.87269
Depreciation-36.18-34.74-34.57-34.21-33.28-136.80
EBIT77.96+67.3%39.96-21.7367.3846.59132.20
PBT51.23+106.4%21.48-62.1937.1024.8221.21
Tax000000
Equity11.4611.4611.46011.4511.46
OPM11.385.10-21.099.897.611.49
Net Profit51.23+106.4%21.48-62.1937.1024.8221.21
NPM11.385.10-21.099.897.611.49
EPS4.47+106.0%1.87-5.433.242.171.85

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue1,405.38+8.1%1,299.59
Other Income15.0117.68
Total Income1,420.39+7.8%1,317.27
Expenditure-1,393.76-13.6%-1,226.48
Interest-120.58-161.65
PBDT00
EBITDA269-27.2%369.27
Depreciation-136.80-134.51
EBIT132.20-43.7%234.76
PBT21.21+198.8%-21.46
Tax041.46
Equity11.4611.44
OPM (%)1.49-1.63
Net Profit21.21+9.8%19.31
NPM (%)1.491.47
EPS (Rs)1.85+2.2%1.81
CEPS1.851.81

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue449.02+37.2%428.22290.34375.76327.271,421.59
Other Income3.802.094.633.045.2715.02
Total Income452.83+36.2%430.31294.97378.80332.541,436.61
Interest30.8122.5138.2333.9627.48122.19
Expenditure-428.23-28.2%-430.64-380.89-373.06-334.07-1,518.65
PBDT000000
EBITDA123.35+39.4%91.9217.32106.4988.48304.22
Depreciation-71.75-71.83-69.64-69.83-67.80-279.09
EBIT51.60+149.5%20.09-52.3236.6620.6825.13
PBT20.29+561.1%-0.2905.74-4.40-91.96
Tax4.704.894.314.744.2118.16
Equity11.4611.460011.4511.46
OPM4.48-0.070.001.52-1.32-6.40
Net Profit25+13257.9%4.60-88.7010.49-0.19-73.80
NPM5.521.07-30.072.77-0.06-5.14
EPS2.18+11000.0%0-7.740.92-0.020

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue1,421.59-1.6%1,444.85
Other Income15.0217.47
Total Income1,436.61-1.8%1,462.33
Expenditure-1,518.65-7.1%-1,418.55
Interest-122.19-166.32
PBDT00
EBITDA304.22-34.8%466.50
Depreciation-279.09-273.88
EBIT25.13-87.0%192.62
PBT-91.96-37.1%-67.07
Tax18.1649.79
Equity11.4611.44
OPM (%)-6.40-4.59
Net Profit-73.80-310.7%-17.97
NPM (%)-5.14-1.23
EPS (Rs)00
CEPS00

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers